FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and can be used for treatment of optic nerve atrophy of different etiology. Tree-component complex is implanted to patient in such a way that it covers optic nerve, posterior short ciliary arteries and part of retrobulbar cellular tissue, without joining them. Three-component complex contains mesenchymal stem cells, labeled with magnetic microparticles. Cells are transposed into biological or synthetic fine-porous material, which is tightly connected with polymer magnetic material with induction of constant magnetic field 1.5 mT, with multi-polar reversible magnetisation.
EFFECT: invention ensures improvement or stable stabilisation of visual functions, extension of vision field boundaries, acceleration of hemodynamics in retina and optic nerve.
2 cl
Title | Year | Author | Number |
---|---|---|---|
THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2012 |
|
RU2485922C1 |
METHOD OF SURGICAL TREATMENT OF PROGRESSING AND COMPLICATED MYOPIA | 2012 |
|
RU2494711C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2471458C1 |
METHOD FOR SURGICAL TREATMENT OF ACUTE AND CHRONIC DISORDERS IN OCULAR CIRCULATION (VARIANTS) | 2003 |
|
RU2236204C1 |
METHOD FOR INTEGRATED PATHOGENETIC TREATMENT OF CENTRAL AND PERIPHERAL TAPETORETINAL DYSTROPHIES WITH APPLYING CELL TECHNOLOGIES | 2011 |
|
RU2467730C2 |
METHOD FOR TREATING ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2791648C1 |
SURGICAL METHOD FOR TREATING THE CASES OF CENTRAL RETINAL VEIN THROMBOSIS | 2003 |
|
RU2235529C1 |
Authors
Dates
2013-10-10—Published
2012-05-18—Filed